Downregulation of the AT1A receptor by pharmacologic concentrations of angiotensin-(1-7)

Journal of Cardiovascular Pharmacology

Volumn 37, Issue 4, 2001, Pages 437-448

  Clark, M A ^a   Tallant, E A ^a   Diz, D I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Angiotensin (1 7); AT1 receptor; Chinese hamster ovary cells; Phospholipase C

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN[1-7]; DIPEPTIDYL CARBOXYPEPTIDASE; INOSITOL PHOSPHATE; UNCLASSIFIED DRUG; ANGIOTENSIN I; ANGIOTENSIN I (1 7); ANGIOTENSIN I (1-7); ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; PEPTIDE FRAGMENT;

ANIMAL CELL; ARTICLE; BLOOD VESSEL REACTIVITY; CHO CELL; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; ANIMAL; DOSE RESPONSE; DOWN REGULATION; GENETICS; HAMSTER; METABOLISM; PHYSIOLOGY; RADIOASSAY;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; CHO CELLS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; INOSITOL PHOSPHATES; PEPTIDE FRAGMENTS; RADIOLIGAND ASSAY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN;

EID: 0034745178     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200104000-00011     Document Type: Article

References (54)

1. Counter-regulatory actions of angiotensin-(1-7)
2. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth
3. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury
4. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: Implications for a novel angiotensin receptor
5. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide
6. Receptor-mediated vasodilation effect of angiotensin-(1-7) (angiotensin 1-7) in the isolated rabbit afferent arteriole (Af-Art)
7. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds
8. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats
9. Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats
10. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension
11. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor
12. Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): Evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors
13. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle
14. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan
15. Cardiovascular actions of angiotensin-(1-7)
16. Angiotensin-(1-7) is an antagonist at the type I angiotensin II receptor
17. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system
18. Alterations in prostaglandin production in spontaneously hypertensive rat smooth muscle cells
19. Angiotensin-(1-7) binding at angiotensin II receptors in the rat brain
20. Full and partial agonists induce distinct desensitized states of the 5-HT3 receptor
21. Hypothalamic substance P release. Attenuated angiotensin responses in mRen2(27) transgenic rats
22. NK1 receptor antagonist blocks angiotensin II responses in renin transgenic rat
23. 1BR)
24. Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells
25. Identification of angiotensin-(1-7) in rat brain: Evidence for differential processing of angiotensin peptides
26. Protein measurement with the Folin-Phenol reagent
27. Angiotensin II activates distinct signal transduction pathways in astrocytes isolated from neonatal rat brain
28. Angiotensin II receptor pharmacology
29. Molecular mechanisms of angiotensin II receptor internalization
30. Characterization of angiotensin receptors
31. 1 receptor in vascular smooth muscle?
32. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells
33. Human astrocytes contain two distinct angiotensin receptor subtypes
34. 1b receptors: Pharmacological and functional requirements
35. Agonist-induced endocytosis and signal generation in adrenal glomerulosa cells. A potential mechanism for receptor-operated calcium entry
36. Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man
37. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats
38. Cardiovascular actions of angiotensin-(1-7) microinjected into the dorsomedial medulla of rats
39. Natriuretic action of angiotensin-(1-7)
40. Renal actions of angiotensin-(1-7) in vivo and in vitro studies
41. Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts
42. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats
43. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides
44. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme
45. Angiotensin-(1-7). A member of circulating angiotensin peptides
46. Differential regulation of angiotensin peptide levels in plasma and kidney of the rat
47. Differential actions of angiotensin II and angiotensin-(1-7) on transmitter release
48. Role of angiotensin-(1-7) in modulation of the baroreflex in renovascular hypertensive rats
49. Long-term captopril treatment. Angiotensin II receptors and responses
50. Signal transduction mechanism involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells
51. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7)
52. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system
53. 1 receptor gene expression in transgenic (mRen-2) 27 rats
54. Downregulation of angiotensin II type I receptor by nitric oxide